Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial

Affiliations

• ¹ McGill University Health Centre, Montreal, Quebec, Canada.
• ² The George Institute for Global Health, UNSW Sydney, Sydney, Australia.
• ³ Royal North Shore Hospital, Sydney, Australia.
• ⁴ New Arch Consulting, Seattle, Washington, USA.
• ⁵ Janssen Inc., Toronto, Ontario, Canada.
• ⁶ Faculty of Medicine, UNSW Sydney, Sydney, Australia.
• ⁷ Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
• ⁸ Sydney Medical School, University of Sydney, Sydney, Australia.
• ⁹ St. Paul's Hospital, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
• ¹⁰ Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
• ¹¹ Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, Ontario, Canada.
• ¹² The Royal North Shore Hospital, Sydney, Australia.
• ¹³ Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.